Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Silverstein

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Biomarkers in Neuropsychiatry|September 25, 2025
Electroretinographic dysfunction, insulin resistance, and childhood trauma in early-course psychosis: A case-control exploratory studyErik Velez-Perez, Nicolas Raymond, Chelsea Kiely, et al.
Journal of the American Dental Association (1939)|June 2, 2012
The effect of training on the use of tobacco-use cessation guidelines in dental settingsMargaret M Walsh, Marilyn Belek, Preeti Prakash, et al.
JAMA Network Open|November 15, 2021
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic RetinopathyEli Ipp, David Liljenquist, Bruce Bode, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Genetic susceptibility to schizophrenia through neuroinflammatory pathways is associated with retinal thinning: Findings from the UK-BiobankFinn Rabe, Lukasz Smigielski, Foivos Georgiadis, et al.
Nature. Mental Health|May 14, 2025
Genetic susceptibility to schizophrenia through neuroinflammatory pathways associated with retinal thinnessFinn Rabe, Lukasz Smigielski, Foivos Georgiadis, et al.
Research Square|May 19, 2025
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanismsTrevor Williams, Jim Gold, James Waltz, et al.
Biological Psychiatry|May 10, 2008
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia InitiativeCameron S Carter, Deanna M Barch, Robert W Buchanan, et al.
Schizophrenia Bulletin|November 22, 2008
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meetingDeanna M Barch, Cameron S Carter, Amy Arnsten, et al.
Schizophrenia Bulletin Open|December 19, 2025
Baseline Social Functioning Is Associated with Increased Likelihood of Remission from a Clinical High Risk for Psychosis SyndromeMaeve Hoffman, Luz Maria Alliende, Victor Pokorny, et al.
Biological Psychiatry|May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disordersCameron S Carter, Deanna M Barch, Edward Bullmore, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Biomarkers in Neuropsychiatry|September 25, 2025
Electroretinographic dysfunction, insulin resistance, and childhood trauma in early-course psychosis: A case-control exploratory studyErik Velez-Perez, Nicolas Raymond, Chelsea Kiely, et al.
Journal of the American Dental Association (1939)|June 2, 2012
The effect of training on the use of tobacco-use cessation guidelines in dental settingsMargaret M Walsh, Marilyn Belek, Preeti Prakash, et al.
JAMA Network Open|November 15, 2021
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic RetinopathyEli Ipp, David Liljenquist, Bruce Bode, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Genetic susceptibility to schizophrenia through neuroinflammatory pathways is associated with retinal thinning: Findings from the UK-BiobankFinn Rabe, Lukasz Smigielski, Foivos Georgiadis, et al.
Nature. Mental Health|May 14, 2025
Genetic susceptibility to schizophrenia through neuroinflammatory pathways associated with retinal thinnessFinn Rabe, Lukasz Smigielski, Foivos Georgiadis, et al.
Research Square|May 19, 2025
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanismsTrevor Williams, Jim Gold, James Waltz, et al.
Biological Psychiatry|May 10, 2008
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia InitiativeCameron S Carter, Deanna M Barch, Robert W Buchanan, et al.
Schizophrenia Bulletin|November 22, 2008
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meetingDeanna M Barch, Cameron S Carter, Amy Arnsten, et al.
Schizophrenia Bulletin Open|December 19, 2025
Baseline Social Functioning Is Associated with Increased Likelihood of Remission from a Clinical High Risk for Psychosis SyndromeMaeve Hoffman, Luz Maria Alliende, Victor Pokorny, et al.
Biological Psychiatry|May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disordersCameron S Carter, Deanna M Barch, Edward Bullmore, et al.
Pageof 4